The Phoenix Mills Ltd. (PDF)
Top Losers
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
Adani Ports and SEZ
Kilitch Drugs (India) Ltd. Share Price
Pharmaceuticals & DrugsKilitch Drugs (India) Ltd. (INR)4552.1 (0.5%) 
Exchange ScripsBSE524500NSEKILITCHISININE729D01010
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Kilitch Drugs (India) Ltd. Performance
Market performance
Open price457.9
High457.9
Volumes8930
Prev Close455
Low443.15
Closing date2025-06-11
Historical performance
1 Year High499.00
3 Year High499.00
5 Year High499.00
1 Year Low299.95
3 Year Low125.00
5 Year Low78.60
Kilitch Drugs (India) Ltd. Fundamentals
Company Valuation
Market Cap (₹Cr)
NaN
Face Value (₹)
P/E Ratio
Dividend Yield
N/A
Kilitch Drugs (India) Ltd. Investment Returns
1 Year
35.5%
3 Years
170.4%
5 Years
261.3%
10 Years
1633.3%
Kilitch Drugs (India) Ltd. Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 447.52 | Bullish |
| 10-DMA | 439.18 | Bullish |
| 20-DMA | 448.44 | Bullish |
| 50-DMA | 397.63 | Bullish |
| 100-DMA | 360.8 | Bullish |
| 200-DMA | 346.78 | Bullish |
Shareholding Pattern
| Field | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 |
|---|---|---|---|---|---|
| Promoters | 4 | 4 | 4 | 3 | 3 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 4 | 4 | 4 | 3 | 3 |
| Public Investors | 9745 | 10135 | 9916 | 9617 | 9522 |
| Government | --- | --- | --- | --- | --- |
Kilitch Drugs (India) Ltd. Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Other Income | 45 | 29 | 29 | 27 |
| Operating Profit | 287 | 206 | 134 | 80 |
| Interest | 60 | 51 | 13 | 9 |
| Depreciation | 33 | 36 | 25 | 20 |
| Profit Before Tax | 194 | 120 | 96 | 51 |
| Consolidated Net Profit | 146 | 104 | 74 | 37 |
| Adjusted EPS | 9 | 7 | 5 | 2 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Share Capital | 161 | 156 | 156 | 155 |
| Total Reserves | 1599 | 1307 | 1206 | 1113 |
| Minority Interest | -6 | -10 | 12 | 24 |
| Total Non-Current Liabilities | -24 | -19 | -12 | -9 |
| Total Liabilities | 2375 | 2175 | 2083 | 2019 |
| Capital Work in Progress | 60 | 36 | 32 | 655 |
| Total Assets | 2375 | 2175 | 2083 | 2019 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | -1 | 26 | 58 | 457 |
| Cash Flow from Investing Activities | -95 | 79 | -153 | -376 |
| Cash Flow from Financing Activitie | 88 | -7 | 70 | 16 |
| Net Cash Inflow / Outflow | -9 | 98 | -24 | 97 |
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 50.11.
- 3Y Stock Price CAGR of the stock is 41.7.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹287 Million.
- The company generated revenue of ₹1544 Million in the previous financial year.
Kilitch Drugs (India) Ltd.
4552.1 (0.5%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1376493.7
No. of Shares: 3025.3
Performance:37.6%
P/L: ₹376493.7
Top Gainers
| Symbol | Change% |
|---|---|
| GTL | 11.18(20%) |
| KARMAENG | 69.55(20%) |
| ENERGYDEV | 26.53(20%) |
| GTLINFRA | 1.81(20%) |
| ANTGRAPHIC | 1.51(20%) |
Similar stocks
Announcing Stock of the Month!
Live video call With Our Agent